PharmaTher Holdings Ltd.
PHRM
CNSX
| 08/31/2025 | 05/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -37.37% | 44.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -37.67% | 53.23% | |||
| Operating Income | 37.67% | -53.23% | |||
| Income Before Tax | -10.15% | -12.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.15% | -12.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.15% | -12.59% | |||
| EBIT | 37.67% | -53.23% | |||
| EBITDA | -- | -53.25% | |||
| EPS Basic | -6.06% | -13.79% | |||
| Normalized Basic EPS | 37.04% | -50.00% | |||
| EPS Diluted | -6.06% | -13.79% | |||
| Normalized Diluted EPS | 37.04% | -50.00% | |||
| Average Basic Shares Outstanding | 2.71% | 0.00% | |||
| Average Diluted Shares Outstanding | 2.71% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||